Blueprint Medicines (BPMC) PT Lowered to $94 at Guggenheim

April 28, 2020 12:26 PM EDT Send to a Friend

Guggenheim analyst Michael W. Schmidt ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Blueprint Medicines (BPMC) PT Lowered to $94 at Guggenheim

Member Login

Free News Feed